Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-19

FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Carbidopa and Levodopa submitted by Zydus Pharmaceuticals USA Inc., approving an amendment to the product's labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

SUPPL AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)